VaughanD.The dark side of organizations: mistake, misconduct, and disaster. Annu Rev Sociol1999; 25: 271–305.
3.
DekkerS.Just Culture, Balancing Safety and Accountability.Ashgate Publishing Company, 2007.
4.
KiselevaY.A., CaylorK.L., RoyerRM. Noninvasive vascular testing with the surgeon present in the planning and maintenance of arteriovenous hemodialysis access. Journal for Vascular Ultrasound2006; 3: 141–8.
5.
UNOS Center specific report 2004 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994–2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
6.
GallieniM., SaxenaR., DavidsonI.Dialysis access in Europe and in North America: Are we on the same path?Seminars in International Radiology2009; 26: 87–105.
7.
DemberL., BeckG.J., AllonM.. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis- a randomized controlled trial. JAMA2008; 299: 2164–71.
8.
DavidsonI., HackermanC., KapadiaA., MinhajuddibA.Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. J Vasc Access2009; 10: 153–6.
9.
DixonB.S., BeckG.J., VazquezM.A.. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med2009; 360: 2191–201.
10.
CaldwellM.The Tipping Point: How Little Things Can Make a Big Difference.New York: Little Brown & Co, 2000; ISBN 0-316-31696-2.